ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).

Source:http://linkedlifedata.com/resource/pubmed/id/12900771

Download in:

View as

General Info

PMID
12900771